(Q34150886)

31 July 2017

title

Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344) (English)

1 reference

Cancer and Leukemia Group B

31 July 2017

author

8

object named as

Cancer and Leukemia Group B

1 reference

31 July 2017

Nicholas A. Christakis

7

object named as

Nicholas A Christakis

1 reference

31 July 2017

Elizabeth B Lamont

1

1 reference

31 July 2017

James E Herndon

2

1 reference

31 July 2017

Jane C Weeks

3

1 reference

31 July 2017

I Craig Henderson

4

1 reference

31 July 2017

Craig C Earle

5

1 reference

31 July 2017

Richard L Schilsky

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Journal of the National Cancer Institute

31 July 2017

published in

1 reference

31 July 2017

volume

98

1 reference

31 July 2017

issue

18

1 reference

31 July 2017

page(s)

1335-1338

1 reference

Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158031

An algorithm for the use of Medicare claims data to identify women with incident breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158031

A primer and comparative review of major US mortality databases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158031

Studying radiation therapy using SEER-Medicare-linked data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158031

Use of SEER-Medicare data for measuring cancer surgery

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158031

Construct validity of medicare chemotherapy claims: the case of 5FU.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158031

Medicare's common denominator: the covered population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158031

Representation of older patients in cancer treatment trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4158031

Participation of patients 65 years of age or older in cancer clinical trials

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ363

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ363

Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ363

Participation in cancer clinical trials: race-, sex-, and age-based disparities

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16985253

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16985253

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJJ363

1 reference

31 July 2017

1 reference

31 July 2017

1 reference